Capital Ideas
ResearchGet Premium

ACCESS THE LATEST RESEARCH AND INSIGHTS

Valens Strikes a Deal with Canopy

Keep reading for news on Valens GroWorks (CSE:VGW), a bear turning more positive on GE, bottom fishing for semiconductors, and a way to play hemp legalization in the U.S.

Valens Strikes a Deal with Canopy

Keep reading for news on Valens GroWorks (CSE:VGW), a bear turning more positive on GE, bottom fishing for semiconductors, and a way to play hemp legalization in the U.S.


Initiations & Upgrades

Rational advice on how to handle downturns. A biotech developing synthetic CBD treatments with 245% upside. And a utility stock breaking out to an all-time high.

Initiations & Upgrades

Rational advice on how to handle downturns. A biotech developing synthetic CBD treatments with 245% upside. And a utility stock breaking out to an all-time high.


Biotech Could Surge 245% on Manmade CBD Drug

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.

Biotech Could Surge 245% on Manmade CBD Drug

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.


Biotech Leads CBD Race

Today’s Digest will feature clear-eyed investment advice, a stock investors are flocking to, and a biotech working on CBD treatments with huge upside.

Biotech Leads CBD Race

Today’s Digest will feature clear-eyed investment advice, a stock investors are flocking to, and a biotech working on CBD treatments with huge upside.


Prescient Prediction from Cronos CEO

Cronos Group CEO Michael Gorenstein gave us his prognostication on consolidation in the cannabis sector earlier this year. Cronos shares are nearly 40% higher since.

Prescient Prediction from Cronos CEO

Cronos Group CEO Michael Gorenstein gave us his prognostication on consolidation in the cannabis sector earlier this year. Cronos shares are nearly 40% higher since.


Fabrice Taylor Questioned Aphria’s Investment Activities 18 Months Ago on Capital Ideas TV

Capital Ideas contributor Fabrice Taylor dissected Aphria’s trading in June of 2017. See Taylor’s analysis of Aphria’s activities and the response of company CEO Vic Neufeld.

Fabrice Taylor Questioned Aphria’s Investment Activities 18 Months Ago on Capital Ideas TV

Capital Ideas contributor Fabrice Taylor dissected Aphria’s trading in June of 2017. See Taylor’s analysis of Aphria’s activities and the response of company CEO Vic Neufeld.


Rough Open, Canopy Deal & New CEO Video

Hear about the strategy shift Peekaboo Beans has implemented to “supercharge” growth. And look out for an interview with the CEO of a cannabis company building a global footprint.

Rough Open, Canopy Deal & New CEO Video

Hear about the strategy shift Peekaboo Beans has implemented to “supercharge” growth. And look out for an interview with the CEO of a cannabis company building a global footprint.


Already Up 1,000% in Three Years & Still Could Gain 140%.

Coverage of a stock that could add to its 1,000% gain. The new Digest on a company with takeout potential. Watch the replay of our live interview with Kintavar’s CEO.

Already Up 1,000% in Three Years & Still Could Gain 140%.

Coverage of a stock that could add to its 1,000% gain. The new Digest on a company with takeout potential. Watch the replay of our live interview with Kintavar’s CEO.



Error X
Your e-mails don't match.
Close